{
  "id": "193136b042cf9b37",
  "title": "STAT+: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested",
  "description": "Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.",
  "content": "Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/02/11/merck-aids-hiv-access-gilead-pricing/?utm_campaign=rss",
  "published_at": "2026-02-11T21:21:53+00:00",
  "fetched_at": "2026-02-12T00:28:38.246764+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested",
    "description": "Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.",
    "url": "https://www.statnews.com/pharmalot/2026/02/11/merck-aids-hiv-access-gilead-pricing/?utm_campaign=rss",
    "published": "2026-02-11T21:21:53+00:00",
    "source": "STAT"
  }
}